Silicon Labs Q3 revenue beats estimates; suspends guidance

By Reuters News


Overview

  • Wireless IoT chipmaker's Q3 revenue rose 22% yr/yr, beating analyst expectations

  • Adjusted EPS for Q3 rose 228% yr/yr

  • Company suspended guidance due to pending Texas Instruments acquisition


Outlook

  • Company has suspended providing forward-looking guidance due to pending Texas Instruments acquisition

  • Company says backlog and design-win ramps position it for continued revenue growth

  • Company notes healthy demand environment and low distributor and customer inventories


Result Drivers

  • BROAD-BASED GROWTH - Co said Q3 revenue was driven by growth across many end applications and a record quarter for medical revenue, per CEO Matt Johnson

  • MEDICAL SEGMENT - Medical revenue increased 48% sequentially and over 300% yr/yr, reaching a new quarterly record

  • INVENTORY LEVELS - Co said distributor and end customer inventories fell to multi-year and near record lows, indicating healthy demand


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$250.89 mln

$242.10 mln (5 Analysts)

Q3 Net Income

$8.85 mln

Q3 Gross Profit

$152.58 mln

Q3 Operating Expenses

$144.63 mln

Q3 Operating Income

$7.95 mln


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the semiconductors peer group is "buy."

  • Wall Street's median 12-month price target for Silicon Laboratories Inc. is $231.00, about 4.1% above its November 9 closing price of $221.80

  • The stock recently traded at 55 times the next 12-month earnings vs. a P/E of 58 three months ago


Reuters Recommended Reads

  • Nov 10 - Chipmakers warn AI demand is creating bottlenecks in automotive supply chain

  • Nov 10 - Chipmaker Infineon forecasts strong 2027 growth on data-centre demand

  • Nov 10 - Germany's Infineon Q4 revenue rises sequentially


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.